Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Region    |    News By Date    |    Business Directory
All Press Releases for February 26, 2009 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



Jim Mazzo Joins MIND Research Institute's Board of Directors
MIND Research Institute Adds Another Powerhouse to Board of Directors 
x-small text small text medium text large text


    SANTA ANA, CA, February 26, 2009 /24-7PressRelease/ -- MIND Research Institute today announced that Jim Mazzo, chairman and chief executive officer of Advanced Medical Optics (AMO), was recently elected to MIND's board of directors. Mr. Mazzo is a strong believer in education. He serves on numerous boards and committees at the University of California at Irvine (UCI) and chairs the UCI Foundation's Board of Trustees, the Engineering Advisory Board Committee, and the Eye Institute Steering Committee. He is also serves on the board of trustees for Chapman University and the University of San Diego.

"'When you want something done, give it to the busiest person you know.' This saying is really true with Jim Mazzo, and the reason why MIND Research Institute welcomes him to our already distinguished board," said Ted Smith, Chairman and CEO. "Mazzo represents the biotechnology field, which depends on employees with strong mathematics and problem-solving skills, which the MIND education process teaches to all students. He is also a go-getter and doer - two of the greatest qualities in a board member."

Mazzo remarked about his new position on the MIND board, "This is an organization that is solving a major problem in American education in an innovative and highly scalable way. I'm excited to be part of their success and anxious to bring my skills and talents to its high powered board."

About The MIND Research Institute

The MIND Research Institute is a neuroscience and education research based, non-profit corporation. MIND applies its distinctive visual approach to illustrating concepts and building problem-solving skills as the basis for innovative, research-proven math education programs for elementary and secondary schools. The programs include the ST Math patent-pending instructional software for K-5 students, ST Math : Algebra Readiness for intervention at the secondary level, and Algebra Readiness: A Blueprint for the Foundation of Algebra a comprehensive program featuring a tightly integrated textbook and courseware. MIND's visual approach taps into each student's innate ability to do spatial-temporal (ST) reasoning and problem-solving, and is effective at engaging students at all levels of language or academic proficiency. There are currently 450 schools in California, Texas and 17 other states, and more than 100,000 students and 4,500 teachers participating in the program. For more information, visit http://www.mindresearch.net.


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #

Press Release Keywords:
Read more Press Releases from Ingrid Ellerbe:
Other Press Release Headlines:

Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Social Media:
Share or bookmark this story using Facebook, Twitter, Digg, and more.

Bookmark and Share
Press Release Contact Information:
Ingrid Ellerbe
MIND Research Institute

Director of Corp Comm
3631 S. Harbor
Santa Ana, CA
USA 92704
Voice: 959.525.6548
Fax: 714.751.5915
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.